IGF-1 LR3 (Insulin-like Growth Factor-1 Long Arginine 3) works by binding to IGF-1 receptors located on muscle satellite cells, initiating signalling pathways that drive protein synthesis while inhibiting protein breakdown
Do the benefits outweigh the risks of combined therapy
To learn more about SGLT2 inhibitors and other glucose-lowering agents, explore the Diabetes in Control article archive
However, immediate medical care is necessary if you experience: Severe or worsening chest pain Chest pain accompanied by difficulty breathing, dizziness, or fainting Vomiting blood or black, tarry stools Persistent vomiting lasting more than 24 hours History of heart disease or risk factors such as high blood pressure, diabetes, or smoking In these situations, prompt evaluation by a healthcare professional is essential to rule out life-threatening conditions
Menopause, 12 (3), 258266